DeSci project NanoVita completes Series A financing, with a post-money valuation of $20 million

GateNews

Gate News update: On April 9, the DeSci project NanoVita announced it has completed its Series A funding round, with a post-money valuation of $20 million. The specific amount raised has not been disclosed. This round was co-invested by K24 Ventures, LandScape Capital, and WestLabs. NanoVita is a decentralized science (DeSci) protocol that combines nanotechnology, AI bio-intelligence, and real-world health data, aiming to build open, on-chain health research infrastructure so that everyone can participate in and benefit from the next generation of personalized health research and the data sovereignty revolution.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments